Ketoconazole

Red

Brand Name(s):

Indication:Cushing’s syndrome (endogenous) in adults and adolescents above the age of 12 years.

Rationale:1,2,3

Considered:Mar-15

Review Date:Nov-25

Comments:
Ketoconazole may have a direct effect on corticotropic tumour cells in patients with Cushing’s disease. It is used under specialist supervision for treatment of endogenous Cushing’s syndrome.